• 5
  • Health A to Z
  • 5
  • Matthew I. Kim, MD – Endocrinology, Diabetes, and Metabolism

Matthew I. Kim, MD – Endocrinology, Diabetes, and Metabolism

Dr. Matthew Kim reviews medical content for Healthwise, a nonprofit organization with a mission to help people make better health decisions. Dr. Kim is an Associate Physician in the Division of Endocrinology, Diabetes, and Hypertension at Brigham and Women’s Hospital in Boston, Massachusetts.

Matthew I. Kim, MD – Endocrinology, Diabetes, and Metabolism

Dr. Matthew Kim reviews medical content for Healthwise, a nonprofit organization with a mission to help people make better health decisions. Dr. Kim is an Associate Physician in the Division of Endocrinology, Diabetes, and Hypertension at Brigham and Women’s Hospital in Boston, Massachusetts.

Education and Training

MD: Washington University School of Medicine, St. Louis, MO, 1996

Internship and Residency in Internal Medicine: Hospital of the University of Pennsylvania, Philadelphia, PA, 1996–1999

Fellowship in Endocrinology and Metabolism: Johns Hopkins University, Baltimore, MD, 1999–2002

National Library of Medicine Applied Fellowship in Medical Informatics: Johns Hopkins University, Baltimore, MD, 2001–2003

Certifications

American Board of Internal Medicine

Endocrinology, Diabetes and Metabolism, American Board of Internal Medicine

Academic Appointments

Associate Physician, Harvard Medical School Brigham and Women’s Hospital, Division of Endocrinology, Diabetes, and Hypertension, Boston, MA, 2009–present

Instructor: Johns Hopkins University, Division of Endocrinology and Metabolism, Baltimore, MD, 2002–2003

Johns Hopkins University, Baltimore, MD:

  • Assistant Professor, Division of Health Sciences Informatics, 2003–2009
  • Assistant Professor, Division of Endocrinology and Metabolism, 2003–2009
  • Instructor, Division of Endocrinology and Metabolism, 2002–2003

Financial Disclosure

The final approval of Healthwise content is always made by a clinician with no financial conflicts.

This reviewer reported no financial conflicts.